Emergent BioSolutions | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
ALKERMES USD 1.51B 46.61M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amarin USD 473.69M 12.49M 2025-03
ANI Pharmaceuticals USD 418.62M 14.94M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Exact Sciences USD 2.4B 5.34M 2025-03
Exelixis USD 2.13B 113.18M 2025-04
Glaxosmithkline GBP 13.67B 337M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ironwood Pharmaceuticals USD -301245000 10.09M 2024-12
Lonza CHF 9.33B 23M 2024-12
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Myriad Genetics USD 704.9M 3.8M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
PTC Therapeutics USD -185760000 912.31M 2025-03
Sanofi 74.07B 3.78B 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03



Emergent BioSolutions Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.